BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7181336)

  • 1. Abnormal immune responses in the ocular presentation of Wiskott-Aldrich syndrome.
    Guss RB; McCulley JP
    Ann Ophthalmol; 1982 Nov; 14(11):1058-60. PubMed ID: 7181336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephropathy in the Wiskott-Aldrich syndrome.
    Spitler LE; Wray BB; Mogerman S; Miller JJ; O'Reilly RJ; Lagios M
    Pediatrics; 1980 Sep; 66(3):391-8. PubMed ID: 7422429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wiskott Aldrich syndrome: a treatable immune disorder. A review.
    Millikan LE
    Mo Med; 1973 Nov; 70(11):764-7 passim. PubMed ID: 4591682
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.
    Altman LC; Snyderman R; Blaese RM
    J Clin Invest; 1974 Aug; 54(2):486-93. PubMed ID: 4136226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update of the Wiskott-Aldrich syndrome. From a new case report.
    Martín Mateos MA; Muñoz-López F; Cruz M
    Allergol Immunopathol (Madr); 1988; 16(2):113-9. PubMed ID: 3394592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenectomy in the management of the thrombocytopenia of the Wiskott-Aldrich syndrome.
    Lum LG; Tubergen DG; Corash L; Blaese RM
    N Engl J Med; 1980 Apr; 302(16):892-6. PubMed ID: 6767187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
    Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
    Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transfer factor and thymosin in the treatment of Wiskott-Aldrich syndrome].
    Franchi F; Segni G; Stabile A; Ammirati P; Aiuti F
    Minerva Pediatr; 1978 Apr; 30(8):609-13. PubMed ID: 661768
    [No Abstract]   [Full Text] [Related]  

  • 9. The Wiskott-Aldrich syndrome. Results of transfer factor therapy.
    Spitler LE; Levin AS; Stites DP; Fudenberg HH; Pirofsky B; August CS; Stiehm ER; Hitzig WH; Gatti RA
    J Clin Invest; 1972 Dec; 51(12):3216-24. PubMed ID: 4640955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eczema in primary immune-deficiencies. Clues to the pathogenesis of atopic dermatitis with special reference to the Wiskott-Aldrich syndrome.
    Saurat JH
    Acta Derm Venereol Suppl (Stockh); 1985; 114():125-8. PubMed ID: 3890446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Congenital deficiency of humoral and cellular immunity].
    Vuković I; Korać D; Stojimirović E; Dinić B
    Bilt Hematol Transfuz; 1977; 5(3-4):47-57. PubMed ID: 307954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent V75M mutation within the Wiskott-Aldrich syndrome protein: description of a homozygous female patient.
    Proust A; Guillet B; Pellier I; Rachieru P; Hoarau C; Claeyssens S; Léonard C; Charrier S; Vainchenker W; Tchernia G; Delaunay J
    Eur J Haematol; 2005 Jul; 75(1):54-9. PubMed ID: 15946311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercatabolism of IgG, IgA, IgM, and albumin in the Wiskott-Aldrich syndrome. A unique disorder of serum protein metabolism.
    Blaese RM; Strober W; Levy AL; Waldmann TA
    J Clin Invest; 1971 Nov; 50(11):2331-8. PubMed ID: 5096517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Wiskott-Aldrich syndrome (literature review)].
    Shabalov NP
    Vopr Okhr Materin Det; 1975 Feb; 20(2):50-4. PubMed ID: 1094723
    [No Abstract]   [Full Text] [Related]  

  • 15. A multiinstitutional survey of the Wiskott-Aldrich syndrome.
    Sullivan KE; Mullen CA; Blaese RM; Winkelstein JA
    J Pediatr; 1994 Dec; 125(6 Pt 1):876-85. PubMed ID: 7996359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two novel mutations identified in the Wiskott-Aldrich syndrome protein gene cause Wiskott-Aldrich syndrome and thrombocytopenia.
    Andreu N; Matamoros N; Escudero A; Fillat C
    Int J Mol Med; 2007 May; 19(5):777-82. PubMed ID: 17390083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer factor therapy: evidence for nonspecificity.
    Ballow M; Dupont B; Hansen JA; Good RA
    Birth Defects Orig Artic Ser; 1975; 11(1):457-61. PubMed ID: 125119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dichotomy of antibody response to group A streptococcal antigens in Wiskott-Aldrich syndrome.
    Ayoub EM; Dudding BA; Cooper MD
    J Lab Clin Med; 1968 Dec; 72(6):971-9. PubMed ID: 5723120
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute immune complex mediated glomerulonephritis in a Chinese girl with Wiskott-Aldrich syndrome variant.
    Lin CY; Hsu HC
    Ann Allergy; 1984 Jul; 53(1):74-8. PubMed ID: 6377982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Some immunohematological aspects of 2 cases of the Wiskott-Aldrich syndrome].
    Ferrara M; Ponte G; Esposito L
    Pediatria (Napoli); 1983; 91(1):75-80. PubMed ID: 6604260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.